Key result
Catheter ablation of typical and atypical atrial flutters was described in a patient with prior transcatheter tricuspid valve replacement.
Case Report (n=1)
This case report describes the feasibility of catheter ablation for atrial flutter in a patient with a prior transcatheter tricuspid valve replacement.
Supports feasibility after transcatheter tricuspid valve replacement; hypothesis-generating for safety and efficacy in larger cohorts.
Tricuspid regurgitation (TR) is a common form of valvular heart disease and has been associated with adverse outcomes including heart failure and an increased risk of mortality.1 This may be particularly true in patients with coexisting atrial arrhythmias.2,3 Surgical management of isolated TR has traditionally been avoided owing to relatively high surgical risk.4 Recently, transcatheter tricuspid valve replacement (TTVR) using the EVOQUE system has shown promise as a safe and effective treatment for patients with severe TR.
No takes yet. Share an insight, caveat, or question.
Braunstein et al. (2022) conducted a case report in Atrial flutter and tricuspid regurgitation (n=1). Catheter ablation was evaluated. Catheter ablation of typical and atypical atrial flutters was described in a patient with prior transcatheter tricuspid valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: